Resistance to second-generation androgen receptor antagonists in prostate cancer | Nature Reviews Urology
Steroidal CYP17 Inhibitors for Prostate Cancer Treatment: From Concept to Clinic | IntechOpen
PDF) CYP17 inhibitors - Abiraterone, C17,20-lyase inhibitors and multi-targeting agents
P450 Signaling | CYP450
Steroidal CYP17 Inhibitors for Prostate Cancer Treatment: From Concept to Clinic | IntechOpen
Computational insight into crucial binding features for metabolic specificity of cytochrome P450 17A1 - ScienceDirect
CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents | Nature Reviews Urology
Steroidal CYP17 Inhibitors for Prostate Cancer Treatment: From Concept to Clinic | IntechOpen
CYP17A1 inhibitor - Wikipedia
CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer | British Journal of Cancer
CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials Cao Q, Bai P, Shi D, Liao J, Shi H, Xing Y, Chen K, Zhang X -
References in Functional characterization of mutant CYP17 genes isolated from a 17α-hydroxylase/17,20-lyase-deficient patient - Metabolism - Clinical and Experimental
Cytochrome b5 modulation of 17α hydroxylase and 17–20 lyase (CYP17) activities in steroidogenesis in: Journal of Endocrinology Volume 187 Issue 2 (2005)
CYP17 inhibition as a hormonal strategy for prostate cancer | Nature Reviews Urology
CYP17 inhibitors for prostate cancer therapy - ScienceDirect
CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials Cao Q, Bai P, Shi D, Liao J, Shi H, Xing Y, Chen K, Zhang X -
Figure 1 from CYP17 inhibition as a hormonal strategy for prostate cancer | Semantic Scholar
Cancers | Free Full-Text | Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced? | HTML
Steroid/androgen synthesis pathway and the sites of inhibition of... | Download Scientific Diagram
Antitumor Activity with CYP17 Blockade Indicates That Castration-Resistant Prostate Cancer Frequently Remains Hormone Driven | Cancer Research
CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents | Nature Reviews Urology
Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation. | Semantic Scholar
Frontiers | Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer | Oncology
Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors | Scientific Reports
CYP17 inhibitors for prostate cancer therapy - ScienceDirect
